Daniel Bélanger
Human Resources Officer at REPARE THERAPEUTICS INC.
Net worth: 4 911 $ as of 2024-04-29
Profile
Daniel Bélanger is currently the Executive Vice President-Human Resources at Repare Therapeutics, Inc. and the Chief Human Resources Officer at Adare Pharma Solutions, Inc. He is also a Member of the Ordre des Conseillers en ressources humaines agréés.
Mr. Bélanger completed his undergraduate degree at the University of Montréal.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
REPARE THERAPEUTICS INC.
0.00% | 2024-02-29 | 1,559 ( 0.00% ) | 4 911 $ | 2024-04-29 |
Daniel Bélanger active positions
Companies | Position | Start |
---|---|---|
REPARE THERAPEUTICS INC. | Human Resources Officer | 2023-05-08 |
Adare Pharma Solutions, Inc.
Adare Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Adare Pharma Solutions, Inc. provides pharmaceutical outsourcing services. Its technologies are used to develop novel prescription and OTC products. Its brands include Viactiv, and Lactéol. The company was founded in 1999 and is headquartered in Lawrenceville, NJ. | Human Resources Officer | 2014-12-31 |
Ordre des Conseillers en ressources humaines agréés | Corporate Officer/Principal | - |
Training of Daniel Bélanger
University of Montréal | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
REPARE THERAPEUTICS INC. | Health Technology |
Private companies | 2 |
---|---|
Adare Pharma Solutions, Inc.
Adare Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Adare Pharma Solutions, Inc. provides pharmaceutical outsourcing services. Its technologies are used to develop novel prescription and OTC products. Its brands include Viactiv, and Lactéol. The company was founded in 1999 and is headquartered in Lawrenceville, NJ. | Health Technology |
Ordre des Conseillers en ressources humaines agréés |
- Stock Market
- Insiders
- Daniel Bélanger